- Home
- RRBI vs ALDX Comparison
RRBI vs ALDX Comparison
Compare RRBI & ALDX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- RRBI
- ALDX
- Stock Information
- Founded
- RRBI 1998
- ALDX 2004
- Country
- RRBI United States
- ALDX United States
- Employees
- RRBI N/A
- ALDX N/A
- Industry
- RRBI Hotels/Resorts
- ALDX Biotechnology: Pharmaceutical Preparations
- Sector
- RRBI Consumer Discretionary
- ALDX Health Care
- Exchange
- RRBI Nasdaq
- ALDX Nasdaq
- Market Cap
- RRBI 406.6M
- ALDX 326.6M
- IPO Year
- RRBI 2019
- ALDX 2014
- Fundamental
- Price
- RRBI $66.23
- ALDX $5.85
- Analyst Decision
- RRBI Buy
- ALDX Strong Buy
- Analyst Count
- RRBI 1
- ALDX 2
- Target Price
- RRBI $67.00
- ALDX $9.50
- AVG Volume (30 Days)
- RRBI 10.8K
- ALDX 849.3K
- Earning Date
- RRBI 07-30-2025
- ALDX 08-07-2025
- Dividend Yield
- RRBI 0.73%
- ALDX N/A
- EPS Growth
- RRBI 23.60
- ALDX N/A
- EPS
- RRBI 5.67
- ALDX N/A
- Revenue
- RRBI $115,623,000.00
- ALDX N/A
- Revenue This Year
- RRBI $5.20
- ALDX N/A
- Revenue Next Year
- RRBI $17.47
- ALDX $43.00
- P/E Ratio
- RRBI $11.58
- ALDX N/A
- Revenue Growth
- RRBI 10.19
- ALDX N/A
- 52 Week Low
- RRBI $46.33
- ALDX $1.14
- 52 Week High
- RRBI $66.40
- ALDX $7.20
- Technical
- Relative Strength Index (RSI)
- RRBI 65.37
- ALDX 69.70
- Support Level
- RRBI $61.25
- ALDX $5.34
- Resistance Level
- RRBI $66.40
- ALDX $5.92
- Average True Range (ATR)
- RRBI 1.47
- ALDX 0.26
- MACD
- RRBI 0.32
- ALDX 0.01
- Stochastic Oscillator
- RRBI 96.86
- ALDX 81.13
About RRBI Red River Bancshares Inc.
Red River Bancshares Inc is the bank holding company for the red river bank. The principal business of the Bank is lending and accepting deposits from businesses, professionals, individuals, and public entities. The bank's primary deposit products are demand deposits, savings deposits, and time deposits. The bank maintains a diversified loan portfolio with a focus on commercial real estate (Owner Occupied and Non-Owner Occupied), one-to-four-family residential, commercial, and industrial loans, construction and development Loans, and others. also, provides Treasury Management Services, Private Banking Services, Brokerage Services, and Other Banking Services.
About ALDX Aldeyra Therapeutics Inc.
Aldeyra Therapeutics Inc is a biotechnology company engaged in developing and commercializing next-generation medicines to improve the lives of patients with immune-mediated and metabolic diseases. The company's product candidate, Reproxalap, is a treatment in late-stage development for dry eye disease and allergic conjunctivitis. In addition, it also has additional product candidates in development for proliferative vitreoretinopathy, primary vitreoretinal lymphoma and other retinal diseases, autoimmune disease, and cancer. Company products includes ADX248, ADX743, ADX631, ADX246, ADX629, ADX2191.